Cargando…

The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments

Most frameworks for family planning include both access and demand interventions. Understanding how these two are linked and when each should be prioritized is difficult. The maximum contraceptive prevalence ‘demand curve’ was created based on a relationship between the modern contraceptive prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinberger, Michelle, Sonneveldt, Emily, Stover, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771155/
https://www.ncbi.nlm.nih.gov/pubmed/29355228
http://dx.doi.org/10.12688/gatesopenres.12780.1
_version_ 1783293211877310464
author Weinberger, Michelle
Sonneveldt, Emily
Stover, John
author_facet Weinberger, Michelle
Sonneveldt, Emily
Stover, John
author_sort Weinberger, Michelle
collection PubMed
description Most frameworks for family planning include both access and demand interventions. Understanding how these two are linked and when each should be prioritized is difficult. The maximum contraceptive prevalence ‘demand curve’ was created based on a relationship between the modern contraceptive prevalence rate (mCPR) and mean ideal number of children to allow for a quantitative assessment of the balance between access and demand interventions. The curve represents the maximum mCPR that is likely to be seen given fertility intentions and related norms and constructs that influence contraceptive use. The gap between a country’s mCPR and this maximum is referred to as the ‘potential use gap.’ This concept can be used by countries to prioritize access investments where the gap is large, and discuss implications for future contraceptive use where the gap is small. It is also used within the FP Goals model to ensure mCPR growth from access interventions does not exceed available demand.
format Online
Article
Text
id pubmed-5771155
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-57711552018-01-19 The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments Weinberger, Michelle Sonneveldt, Emily Stover, John Gates Open Res Method Article Most frameworks for family planning include both access and demand interventions. Understanding how these two are linked and when each should be prioritized is difficult. The maximum contraceptive prevalence ‘demand curve’ was created based on a relationship between the modern contraceptive prevalence rate (mCPR) and mean ideal number of children to allow for a quantitative assessment of the balance between access and demand interventions. The curve represents the maximum mCPR that is likely to be seen given fertility intentions and related norms and constructs that influence contraceptive use. The gap between a country’s mCPR and this maximum is referred to as the ‘potential use gap.’ This concept can be used by countries to prioritize access investments where the gap is large, and discuss implications for future contraceptive use where the gap is small. It is also used within the FP Goals model to ensure mCPR growth from access interventions does not exceed available demand. F1000 Research Limited 2017-12-22 /pmc/articles/PMC5771155/ /pubmed/29355228 http://dx.doi.org/10.12688/gatesopenres.12780.1 Text en Copyright: © 2017 Weinberger M et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Method Article
Weinberger, Michelle
Sonneveldt, Emily
Stover, John
The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
title The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
title_full The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
title_fullStr The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
title_full_unstemmed The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
title_short The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
title_sort maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
topic Method Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771155/
https://www.ncbi.nlm.nih.gov/pubmed/29355228
http://dx.doi.org/10.12688/gatesopenres.12780.1
work_keys_str_mv AT weinbergermichelle themaximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments
AT sonneveldtemily themaximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments
AT stoverjohn themaximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments
AT weinbergermichelle maximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments
AT sonneveldtemily maximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments
AT stoverjohn maximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments